![](/img/cover-not-exists.png)
Cost-effectiveness analysis of irinotecan plus fluorouracil/folinic acid compared with fluorouracil/folinic acid alone as first-line treatment for advanced colorectal cancer
Warren Mark Hart, Carlos Rubio-Terrés, Linda Pronk, Svetlana Kobina, Eduardo Díaz RubioVolume:
5
Pages:
7
DOI:
10.1007/bf02710399
Date:
December, 2003
File:
PDF, 188 KB
2003